Those that received the vaccine lived more than twice as long as the historical, matched, control group, with median survival times of 956 days compared to 423 days. (morrisanimalfoundation.org)
Median survival time for dogs with nosebleeds was 88 days vs. 224 days for dogs with carcinomas that did not have nose bleeds. (vin.com)
«We increased median survival time in animals by 40 %, which gives us enough evidence to go on to human clinical trials,» Belcher says. (protomag.com)